Khi sức mạnh tính toán của AI cũng bắt đầu được "chia sẻ", ai sẽ trở thành người dẫn đầu trong cuộc cạnh tranh mới này?

HelixNano

company

About

Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.

Details

Last Funding Type
Convertable Note
Last Funding Money Raised
$10M
Industries
Artificial Intelligence,Biotechnology,Genetics,Health Care
Founded date
Jan 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re already testing COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
29
$60.30M
HelixNano has raised a total of $60.30M in funding over 2 rounds. Their latest funding was raised on Sep 5, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 5, 2022 Series A 1 Detail
Mar 22, 2022 Series A $45M 3 Milano Investment Partners SGR Detail
Jan 1, 2022 Convertable Note $10M 1 Alameda Research Detail
Sep 30, 2021 Series A 1 Detail
Mar 20, 2020 Convertable Note $110K 3 Detail

Employee Profiles

Number of Employee Profiles
9
HelixNano has 9 current employee profiles, including Executive Hannu Rajaniemi
Executive
Executive
Employee
Employee